The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of CNS involvement in blastic plasmacytoid dendritic cell neoplasm (BPDCN).
 
Irl Brian Greenwell
Consulting or Advisory Role - Acrotech Biopharma; Kyowa Kirin International
Research Funding - Genentech/Abbvie
 
James Davis
No Relationships to Disclose
 
Hong Li
No Relationships to Disclose
 
Deborah Soong
No Relationships to Disclose
 
Justin Taylor
No Relationships to Disclose
 
Andrew A. Lane
Consulting or Advisory Role - Qiagen; Stemline Therapeutics
Research Funding - Abbvie; Stemline Therapeutics
Patents, Royalties, Other Intellectual Property - Methods for determining and treating toxin-conjugate resistance in cancer. (Inst)
 
David Rizzieri
Consulting or Advisory Role - Abbvie; Arog; Bayer; Celgene; Celltrion; Gilead Sciences; Incyte; Jazz Pharmaceuticals; Kite, a Gilead Company; Millenium Pharamceuticals (I); MustangBio; Novartis; Onyx (I); Pfizer; Pharmacyclics; Sanofi; Seagen; Stemline Therapeutics; Teva
Speakers' Bureau - Astellas Pharma; Celgene; Celgene (I); Gilead Sciences; Incyte; Millennium (I); Seagen; Stemline Therapeutics
Research Funding - Abbvie (Inst); Agios (Inst); Ambit BioSciences (Inst); Arog (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); Asuragen (Inst); Bristol-Myers Squibb (Inst); Cantex Pharmaceuticals (Inst); Celator (Inst); Eureka Therapeutics (Inst); FORMA Therapeutics (Inst); Genentech (Inst); Helsinn Healthcare (Inst); KaloBios (Inst); MacroGenics (Inst); MedImmune (Inst); MEI Pharma (Inst); NOHLA Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Sellas Life Sciences (Inst); Stemline Therapeutics (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst)
Expert Testimony - Celltrion